Global Cell Bank 麻豆原创 Research Report 2024

Publication ID:

PB502240914

Publication Date:

March 5, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

A cell bank is a facility that stores cells of specific genome for the purpose of future use in a product or medicinal needs. They often contain expansive amounts of base cell material that can be utilized for various projects.
The global Cell Bank market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Cell Bank is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Cell Bank is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Cell Bank in Viral Cell Bank is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Cell Bank include Charles River, Sigma-Aldrich, WuXi AppTec, Ingestem, SGS Life Sciences, Reliance Life Sciences, Px'Therapeutics, Lonza and Lifecell, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Cell Bank, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cell Bank.
Report Scope
The Cell Bank market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cell Bank market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cell Bank companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
Charles River
Sigma-Aldrich
WuXi AppTec
Ingestem
SGS Life Sciences
Reliance Life Sciences
Px'Therapeutics
Lonza
Lifecell
Goodwin Biotechnology
Globalstem
Cryo-Cell
Tran-Scell Biologics
Toxikon
Segment by Type
Bank Characterization and Testing
Cell Bank Storage
Cell Bank Preparation
Segment by Application
Viral Cell Bank
Master Cell Bank
Working Cell Bank
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cell Bank companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Cell Bank 麻豆原创 Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Bank Characterization and Testing
1.2.3 Cell Bank Storage
1.2.4 Cell Bank Preparation
1.3 麻豆原创 by Application
1.3.1 Global Cell Bank 麻豆原创 Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Viral Cell Bank
1.3.3 Master Cell Bank
1.3.4 Working Cell Bank
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cell Bank 麻豆原创 Perspective (2019-2030)
2.2 Cell Bank Growth Trends by Region
2.2.1 Global Cell Bank 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
2.2.2 Cell Bank Historic 麻豆原创 Size by Region (2019-2024)
2.2.3 Cell Bank Forecasted 麻豆原创 Size by Region (2025-2030)
2.3 Cell Bank 麻豆原创 Dynamics
2.3.1 Cell Bank Industry Trends
2.3.2 Cell Bank 麻豆原创 Drivers
2.3.3 Cell Bank 麻豆原创 Challenges
2.3.4 Cell Bank 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cell Bank Players by Revenue
3.1.1 Global Top Cell Bank Players by Revenue (2019-2024)
3.1.2 Global Cell Bank Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global Cell Bank 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cell Bank Revenue
3.4 Global Cell Bank 麻豆原创 Concentration Ratio
3.4.1 Global Cell Bank 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cell Bank Revenue in 2023
3.5 Cell Bank Key Players Head office and Area Served
3.6 Key Players Cell Bank Product Solution and Service
3.7 Date of Enter into Cell Bank 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 Cell Bank Breakdown Data by Type
4.1 Global Cell Bank Historic 麻豆原创 Size by Type (2019-2024)
4.2 Global Cell Bank Forecasted 麻豆原创 Size by Type (2025-2030)
5 Cell Bank Breakdown Data by Application
5.1 Global Cell Bank Historic 麻豆原创 Size by Application (2019-2024)
5.2 Global Cell Bank Forecasted 麻豆原创 Size by Application (2025-2030)
6 North America
6.1 North America Cell Bank 麻豆原创 Size (2019-2030)
6.2 North America Cell Bank 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Cell Bank 麻豆原创 Size by Country (2019-2024)
6.4 North America Cell Bank 麻豆原创 Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cell Bank 麻豆原创 Size (2019-2030)
7.2 Europe Cell Bank 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Cell Bank 麻豆原创 Size by Country (2019-2024)
7.4 Europe Cell Bank 麻豆原创 Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cell Bank 麻豆原创 Size (2019-2030)
8.2 Asia-Pacific Cell Bank 麻豆原创 Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Cell Bank 麻豆原创 Size by Region (2019-2024)
8.4 Asia-Pacific Cell Bank 麻豆原创 Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cell Bank 麻豆原创 Size (2019-2030)
9.2 Latin America Cell Bank 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Cell Bank 麻豆原创 Size by Country (2019-2024)
9.4 Latin America Cell Bank 麻豆原创 Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cell Bank 麻豆原创 Size (2019-2030)
10.2 Middle East & Africa Cell Bank 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Cell Bank 麻豆原创 Size by Country (2019-2024)
10.4 Middle East & Africa Cell Bank 麻豆原创 Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Charles River
11.1.1 Charles River Company Detail
11.1.2 Charles River Business Overview
11.1.3 Charles River Cell Bank Introduction
11.1.4 Charles River Revenue in Cell Bank Business (2019-2024)
11.1.5 Charles River Recent Development
11.2 Sigma-Aldrich
11.2.1 Sigma-Aldrich Company Detail
11.2.2 Sigma-Aldrich Business Overview
11.2.3 Sigma-Aldrich Cell Bank Introduction
11.2.4 Sigma-Aldrich Revenue in Cell Bank Business (2019-2024)
11.2.5 Sigma-Aldrich Recent Development
11.3 WuXi AppTec
11.3.1 WuXi AppTec Company Detail
11.3.2 WuXi AppTec Business Overview
11.3.3 WuXi AppTec Cell Bank Introduction
11.3.4 WuXi AppTec Revenue in Cell Bank Business (2019-2024)
11.3.5 WuXi AppTec Recent Development
11.4 Ingestem
11.4.1 Ingestem Company Detail
11.4.2 Ingestem Business Overview
11.4.3 Ingestem Cell Bank Introduction
11.4.4 Ingestem Revenue in Cell Bank Business (2019-2024)
11.4.5 Ingestem Recent Development
11.5 SGS Life Sciences
11.5.1 SGS Life Sciences Company Detail
11.5.2 SGS Life Sciences Business Overview
11.5.3 SGS Life Sciences Cell Bank Introduction
11.5.4 SGS Life Sciences Revenue in Cell Bank Business (2019-2024)
11.5.5 SGS Life Sciences Recent Development
11.6 Reliance Life Sciences
11.6.1 Reliance Life Sciences Company Detail
11.6.2 Reliance Life Sciences Business Overview
11.6.3 Reliance Life Sciences Cell Bank Introduction
11.6.4 Reliance Life Sciences Revenue in Cell Bank Business (2019-2024)
11.6.5 Reliance Life Sciences Recent Development
11.7 Px'Therapeutics
11.7.1 Px'Therapeutics Company Detail
11.7.2 Px'Therapeutics Business Overview
11.7.3 Px'Therapeutics Cell Bank Introduction
11.7.4 Px'Therapeutics Revenue in Cell Bank Business (2019-2024)
11.7.5 Px'Therapeutics Recent Development
11.8 Lonza
11.8.1 Lonza Company Detail
11.8.2 Lonza Business Overview
11.8.3 Lonza Cell Bank Introduction
11.8.4 Lonza Revenue in Cell Bank Business (2019-2024)
11.8.5 Lonza Recent Development
11.9 Lifecell
11.9.1 Lifecell Company Detail
11.9.2 Lifecell Business Overview
11.9.3 Lifecell Cell Bank Introduction
11.9.4 Lifecell Revenue in Cell Bank Business (2019-2024)
11.9.5 Lifecell Recent Development
11.10 Goodwin Biotechnology
11.10.1 Goodwin Biotechnology Company Detail
11.10.2 Goodwin Biotechnology Business Overview
11.10.3 Goodwin Biotechnology Cell Bank Introduction
11.10.4 Goodwin Biotechnology Revenue in Cell Bank Business (2019-2024)
11.10.5 Goodwin Biotechnology Recent Development
11.11 Globalstem
11.11.1 Globalstem Company Detail
11.11.2 Globalstem Business Overview
11.11.3 Globalstem Cell Bank Introduction
11.11.4 Globalstem Revenue in Cell Bank Business (2019-2024)
11.11.5 Globalstem Recent Development
11.12 Cryo-Cell
11.12.1 Cryo-Cell Company Detail
11.12.2 Cryo-Cell Business Overview
11.12.3 Cryo-Cell Cell Bank Introduction
11.12.4 Cryo-Cell Revenue in Cell Bank Business (2019-2024)
11.12.5 Cryo-Cell Recent Development
11.13 Tran-Scell Biologics
11.13.1 Tran-Scell Biologics Company Detail
11.13.2 Tran-Scell Biologics Business Overview
11.13.3 Tran-Scell Biologics Cell Bank Introduction
11.13.4 Tran-Scell Biologics Revenue in Cell Bank Business (2019-2024)
11.13.5 Tran-Scell Biologics Recent Development
11.14 Toxikon
11.14.1 Toxikon Company Detail
11.14.2 Toxikon Business Overview
11.14.3 Toxikon Cell Bank Introduction
11.14.4 Toxikon Revenue in Cell Bank Business (2019-2024)
11.14.5 Toxikon Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Charles River
Sigma-Aldrich
WuXi AppTec
Ingestem
SGS Life Sciences
Reliance Life Sciences
Px'Therapeutics
Lonza
Lifecell
Goodwin Biotechnology
Globalstem
Cryo-Cell
Tran-Scell Biologics
Toxikon

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.